Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginFCF Payout RatioGross MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Surgery Partners (SGRY) Net Margin (2016 - 2025)

Surgery Partners (SGRY) has disclosed Net Margin for 12 consecutive years, with 3.28% as the latest value for Q4 2025.

  • Quarterly Net Margin rose 867.0% to 3.28% in Q4 2025 from the year-ago period, while the trailing twelve-month figure was 2.99% through Dec 2025, up 259.0% year-over-year, with the annual reading at 2.99% for FY2025, 259.0% up from the prior year.
  • Net Margin hit 3.28% in Q4 2025 for Surgery Partners, up from 3.08% in the prior quarter.
  • In the past five years, Net Margin ranged from a high of 8.64% in Q2 2023 to a low of 6.11% in Q1 2021.
  • Historically, Net Margin has averaged 0.52% across 5 years, with a median of 0.51% in 2023.
  • Biggest five-year swings in Net Margin: skyrocketed 1163bps in 2023 and later plummeted -1174bps in 2024.
  • Year by year, Net Margin stood at 0.02% in 2021, then tumbled by -20093bps to 3.31% in 2022, then skyrocketed by 292bps to 6.35% in 2023, then tumbled by -185bps to 5.39% in 2024, then surged by 161bps to 3.28% in 2025.
  • Business Quant data shows Net Margin for SGRY at 3.28% in Q4 2025, 3.08% in Q3 2025, and 5.43% in Q2 2025.